Kuldeep Ash Techno Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.50 M
- Revenue Growth %
- Profit Growth 24.84%
- Ebitda 51.30%
- Net Worth -10.56%
- Total Assets -3.42%
About Kuldeep Ash Techno Biotech
Kuldeep Ash Techno Biotech Private Limited (KATBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 June 2013 and has a history of 11 years and eight months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abha Singh and Ankur Gourav serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U26960BR2013PTC020514
- Company No.
020514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2013
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Kuldeep Ash Techno Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abha Singh  | Director | 11-Jun-2013 | Current |
| Ankur Gourav | Director | 28-Aug-2019 | Current |
Financial Performance of Kuldeep Ash Techno Biotech.
Kuldeep Ash Techno Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kuldeep Ash Techno Biotech?
In 2020, Kuldeep Ash Techno Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.50 M
Charges Breakdown by Lending Institutions
- Srei Equipment Finance Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2015 | Srei Equipment Finance Limited | ₹0.50 M | Satisfied |
How Many Employees Work at Kuldeep Ash Techno Biotech?
Unlock and access historical data on people associated with Kuldeep Ash Techno Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kuldeep Ash Techno Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kuldeep Ash Techno Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
